Clear Street’s bioAffinity Technologies BIAFW Stock Holding History

Clear Street’s Portfolio BIAFW Stock Details BIAFW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$7.66K	Hold	54,927	–	–	﹤0.01%	1233
2026 Q1	$24.9K	Sell	54,927 -114	-0.2%	-$36	﹤0.01%	862
2025 Q4	$19.3K	Sell	55,041 -279	-0.5%	-$100	﹤0.01%	722
2025 Q3	$18.3K	Buy	55,320 +198	+0.4%	+$28	﹤0.01%	636
2025 Q2	$7.17K	Hold	55,122	–	–	﹤0.01%	536
2025 Q1	$10.5K	Sell	55,122 -11	-0%	-$5	﹤0.01%	365
2024 Q4	$18.5K	Buy	55,133 +200	+0.4%	+$169	﹤0.01%	281
2024 Q3	$63.2K	Sell	54,933 -11,083	-17%	-$11.5K	﹤0.01%	183
2024 Q2	$19.8K	Buy	66,016 +15,504	+31%	+$7.36K	﹤0.01%	343
2024 Q1	$38.7K	Buy	50,512 +25,112	+99%	+$8.35K	﹤0.01%	226
2023 Q4	$2.18K	Hold	25,400	–	–	﹤0.01%	539
2023 Q3	$2.32K	Buy	25,400 +100	+0.4%	+$30	﹤0.01%	781
2023 Q2	$13K	Buy	25,300 +100	+0.4%	+$31	﹤0.01%	656
2023 Q1	$7.56K	Buy	25,200 +300	+1%	+$112	﹤0.01%	578
2022 Q4	$10K	Sell	24,900 -100	-0.4%	-$44	﹤0.01%	516
2022 Q3	$9K	Buy	+25,000	New	+$25.9K	﹤0.01%	632

Other funds holding BIAFW

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return

Clear Street's BIAFW Position: Q2 2026 in Review

Clear Street held its bioAffinity Technologies (BIAFW) position steady in Q2 2026 at 54,927 shares worth $7.66K. The position accounts for ﹤0.01% of the portfolio, ranked #1233.

Clear Street first reported a position in BIAFW in Q3 2022 and has held it in 16 quarters since. The position peaked at $63.2K in Q3 2024. 4 funds tracked by Wall St. Rank hold BIAFW as of Q2 2026.

Clear Street held 54,927 shares of bioAffinity Technologies worth $7.66K as of Q2 2026.
Clear Street left its bioAffinity Technologies share count unchanged in Q2 2026.
bioAffinity Technologies made up ﹤0.01% of Clear Street's portfolio in Q2 2026, its #1233 holding.
Clear Street first reported a position in bioAffinity Technologies in Q3 2022 and has held it in 16 quarters since.
Clear Street's bioAffinity Technologies position peaked at $63.2K in Q3 2024.
4 funds tracked by Wall St. Rank held bioAffinity Technologies as of Q2 2026.

Based on Clear Street's 13F filing for Q2 2026, filed 12 Aug 2026.